Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03649802 · ClinicalTrials.gov registry record · Phase 2
Vitamin D and Arterial Stiffness in Elderly
A Phase 2 study, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT03649802 is a Phase 2 study that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 52 participants.
The verdict
NCT03649802, a Phase 2 study, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
Investigators will examine arterial stiffness and pulse waveform analysis. Subjects with vitamin D insufficiency will be recruited. A double blind randomized controlled study will examine the effects of standard dose vitamin D3 (800 IU) versus higher dose vitamin D3 (5000 IU)-given on a daily basis.In order to understand mechanisms of action by which vitamin D would improve arterial stiffness investigators will use biomarkers. Oxidative and inflammatory stress will be measured by plasma F2-isoprostanes and Sulforaphane levels.
Interventions
- DIETARY_SUPPLEMENT Low dose vitamin D3
- DIETARY_SUPPLEMENT High dose vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-08-16 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03649802
The ClinicalTrials.gov registry entry for NCT03649802 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low dose vitamin D3 is the first listed.
NCT03649802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03649802 about?
NCT03649802 is a clinical study titled "Vitamin D and Arterial Stiffness in Elderly". Investigators will examine arterial stiffness and pulse waveform analysis. Subjects with vitamin D insufficiency will be recruited. A double blind randomized controlled study will examine the effects of standard dose vitamin D3 (800 IU) versus higher dose vitamin D3 (5000 IU)-given on a daily basis....
What is the current status of trial NCT03649802?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2018-08-16. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03649802?
The interventions under investigation include: Low dose vitamin D3 (DIETARY_SUPPLEMENT), High dose vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03649802?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.